7113 Radiographic findings of drug-induced pneumonitis and clinical correlation in patients with advanced renal cell carcinoma treated with temsirolimus

Maria Santolaya-De Pablo, Anna Berkenblit(ImmunoGen (United States)), Ignacio Durán(Instituto de Biomedicina de Sevilla), Mizue Krygowski, Junko Ohata, G. R. Hudes(Fox Chase Cancer Center), J. Dutcher, Charles S. White(University of Maryland, Baltimore), M. Cincotta(University of Florence)

European Journal of Cancer Supplements

September 1, 2009

10.1016/s1359-6349(09)71446-6

Cited by 11

Related Papers

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

|The Lancet|2016|2.2k

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)

|Clinical Neurophysiology|2014|2.2k

Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines

|Clinical Neurophysiology|2020|1.5k

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

|The Lancet|2017|1.4k

Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial

|Clinical Infectious Diseases|2006|752